NARI RSI Chart
Last 7 days
0.5%
Last 30 days
-2.2%
Last 90 days
-27.3%
Trailing 12 Months
-40.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 520.7M | 0 | 0 | 0 |
2023 | 412.9M | 439.1M | 469.3M | 493.6M |
2022 | 306.3M | 335.6M | 358.9M | 383.5M |
2021 | 170.1M | 208.2M | 242.4M | 277.0M |
2020 | 71.1M | 86.5M | 110.9M | 139.7M |
2019 | 0 | 21.6M | 36.4M | 51.1M |
2018 | 0 | 0 | 0 | 6.8M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 01, 2024 | hoffman william | sold | -1,619,050 | 41.9997 | -38,549 | - |
Apr 24, 2024 | chambers rebecca | acquired | 174,984 | 42.41 | 4,126 | - |
Apr 24, 2024 | lucchese cynthia l | acquired | 174,984 | 42.41 | 4,126 | - |
Apr 24, 2024 | szyman catherine m. | acquired | 174,984 | 42.41 | 4,126 | - |
Apr 24, 2024 | milder donald b | acquired | 174,984 | 42.41 | 4,126 | - |
Apr 24, 2024 | warner robert keith | acquired | 174,984 | 42.41 | 4,126 | - |
Apr 24, 2024 | hoffman william | acquired | 174,984 | 42.41 | 4,126 | - |
Apr 24, 2024 | root jonathan d | acquired | 174,984 | 42.41 | 4,126 | - |
Apr 24, 2024 | mead dana g jr. | acquired | 174,984 | 42.41 | 4,126 | - |
Apr 16, 2024 | hoffman william | sold | -58,040 | 40.00 | -1,451 | - |
Which funds bought or sold NARI recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 07, 2024 | ASSETMARK, INC | added | 24.98 | -51,815 | 626,859 | -% |
May 07, 2024 | Washington Trust Advisors, Inc. | unchanged | - | -779 | 2,208 | -% |
May 07, 2024 | SEI INVESTMENTS CO | sold off | -100 | -6,305,740 | - | -% |
May 07, 2024 | OPPENHEIMER ASSET MANAGEMENT INC. | reduced | -1.29 | -103,524 | 279,244 | -% |
May 07, 2024 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -20.05 | -8,271,000 | 11,946,000 | 0.02% |
May 07, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | reduced | -13.13 | -1,751,090 | 3,140,240 | -% |
May 07, 2024 | Arizona State Retirement System | reduced | -1.28 | -253,304 | 683,427 | -% |
May 07, 2024 | Susquehanna Portfolio Strategies, LLC | sold off | -100 | -1,401,750 | - | -% |
May 07, 2024 | Swiss National Bank | added | 0.59 | -1,694,010 | 4,908,350 | -% |
May 07, 2024 | Lisanti Capital Growth, LLC | sold off | -100 | -2,151,770 | - | -% |
Unveiling Inari Medical Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Inari Medical Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 182.6B | 40.3B | 32.45 | 4.53 | ||||
BDX | 67.4B | 19.7B | 50.6 | 3.42 | ||||
ALGN | 20.6B | 3.9B | 44.54 | 5.26 | ||||
BAX | 18.2B | 14.9B | 6.88 | 1.22 | ||||
MID-CAP | ||||||||
ATR | 10.0B | 3.5B | 31.94 | 2.82 | ||||
HSIC | 9.3B | 12.5B | 24.01 | 0.75 | ||||
BIO | 7.6B | 2.6B | -23.72 | 2.94 | ||||
XRAY | 5.8B | 3.9B | -61.76 | 1.47 | ||||
AXNX | 3.4B | 387.1M | -215.56 | 8.87 | ||||
PDCO | 2.3B | 6.6B | 11.98 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.85 | 0.4 | ||||
ANIK | 423.5M | 169.3M | -5.51 | 2.5 | ||||
ANGO | 236.7M | 324.0M | -1.23 | 0.73 | ||||
APYX | 45.4M | 52.3M | -2.43 | 0.87 | ||||
AEMD | 3.3M | 3.7M | -0.27 | 0.88 |
Inari Medical Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2018Q4 |
Revenue | 8.4% | 143,194,000 | 132,094,000 | 126,366,000 | 119,005,000 | 116,167,000 | 107,771,000 | 96,204,000 | 92,744,000 | 86,752,000 | 83,218,000 | 72,916,000 | 63,453,000 | 57,397,000 | 48,610,500 | 38,715,000 | 25,392,000 | 26,953,000 | 19,887,000 | 14,225,000 | 10,072,000 | - |
Gross Profit | 8.0% | 124,301,000 | 115,088,000 | 111,889,000 | 105,161,000 | 102,426,000 | 94,643,000 | 85,140,000 | 82,397,000 | 76,785,000 | 74,938,000 | 65,876,000 | 58,639,000 | 52,774,000 | 44,925,000 | 35,487,000 | 21,905,000 | 24,247,000 | 17,748,000 | 12,715,000 | 8,741,000 | - |
Operating Expenses | 13.7% | 141,478,000 | 124,385,000 | 109,776,000 | 106,671,000 | 107,764,000 | 100,534,000 | 94,938,000 | 91,725,000 | 79,867,000 | 73,192,000 | 68,603,000 | 54,527,000 | 45,061,000 | 37,929,000 | 28,297,000 | 22,508,000 | 19,411,000 | 16,578,000 | 11,822,000 | 9,383,000 | - |
S&GA Expenses | 1.5% | 103,055,000 | 101,493,000 | 88,284,000 | 85,586,000 | 85,700,000 | 80,122,000 | 75,833,000 | 73,156,000 | 63,732,000 | 54,466,000 | 56,104,000 | 42,897,000 | 36,898,000 | 31,393,000 | 23,080,000 | 18,880,000 | 16,393,000 | 13,869,000 | 10,100,000 | 7,803,000 | - |
R&D Expenses | 17.4% | 26,880,000 | 22,892,000 | 21,492,000 | 21,085,000 | 22,064,000 | 20,412,000 | 19,105,000 | 18,569,000 | 16,135,000 | 18,726,000 | 12,499,000 | 11,630,000 | 8,163,000 | 6,536,000 | 5,217,000 | 3,628,000 | 3,018,000 | 2,709,000 | 1,722,000 | 1,580,000 | - |
EBITDA Margin | -108.4% | 0.00 | 0.02 | 0.02 | -0.02 | -0.05 | -0.06 | -0.04 | -0.03 | 0.01 | 0.05 | 0.08 | 0.13 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 13.0% | 78,000 | 69,000 | 43,000 | 44,000 | 40,000 | 74,000 | 74,000 | 73,000 | 73,000 | 75,000 | 73,000 | 74,000 | 73,000 | 75,000 | 251,000 | 463,000 | 346,000 | 238,000 | 226,000 | 229,000 | - |
Income Taxes | 444.3% | 8,115,000 | 1,491,000 | 2,428,000 | 939,000 | 1,024,000 | 990,000 | 840,000 | 1,252,000 | - | 574,000 | 61,000 | 12,000 | 198,000 | - | - | - | - | -11,000 | 1,000 | - | - |
Earnings Before Taxes | -406.8% | -16,087,000 | -3,174,000 | 5,590,000 | 3,024,000 | -1,194,000 | -4,808,000 | -9,313,000 | -8,935,000 | -3,129,000 | 1,681,000 | -2,743,000 | 4,080,000 | 7,667,000 | 6,985,000 | 6,496,000 | -3,804,000 | 4,112,000 | - | - | - | - |
EBT Margin | -337.7% | -0.02 | 0.01 | 0.01 | -0.03 | -0.06 | -0.07 | -0.05 | -0.04 | 0.00 | 0.04 | 0.07 | 0.12 | - | - | - | - | - | - | - | - | - |
Net Income | -418.8% | -24,202,000 | -4,665,000 | 3,162,000 | 2,085,000 | -2,218,000 | -5,798,000 | -10,153,000 | -10,187,000 | -3,129,000 | 1,107,000 | -2,804,000 | 4,068,000 | 7,469,000 | 6,985,000 | 6,496,000 | -3,804,000 | 4,112,000 | 355,000 | 366,000 | -965,000 | - |
Net Income Margin | -1268.9% | -0.05 | 0.00 | -0.01 | -0.04 | -0.07 | -0.08 | -0.06 | -0.04 | 0.00 | 0.04 | 0.06 | 0.12 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -219.5% | -13,538,000 | 11,332,000 | 14,331,000 | 8,531,000 | -2,977,000 | 9,477,000 | -15,375,000 | -6,180,000 | -11,845,000 | 12,289,000 | -10,330,000 | 2,381,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Assets | -1.8% | 662 | 674 | 549 | 525 | 507 | 504 | 488 | 484 | 484 | 312 | 292 | 254 | 235 | 214 | 206 | 224 | 45.00 |
Current Assets | -1.0% | 233 | 236 | 469 | 445 | 426 | 423 | 411 | 411 | 413 | 245 | 228 | 228 | 221 | 206 | 199 | 220 | 39.00 |
Cash Equivalents | 72.8% | 67.00 | 39.00 | 89.00 | 58.00 | 57.00 | 60.00 | 84.00 | 80.00 | 187 | 93.00 | 81.00 | 91.00 | 103 | 115 | 24.00 | 195 | 24.00 |
Inventory | 4.1% | 45.00 | 43.00 | 40.00 | 39.00 | 36.00 | 33.00 | 30.00 | 27.00 | 24.00 | 21.00 | 19.00 | 18.00 | 14.00 | 11.00 | 7.00 | 6.00 | 4.00 |
Net PPE | -0.8% | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 22.00 | 21.00 | 20.00 | 18.00 | 16.00 | 15.00 | 11.00 | 7.00 | 7.00 | 5.00 | 4.00 | 3.00 |
Goodwill | -2.2% | 210 | 214 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | 2.5% | 215 | 209 | 97.00 | 89.00 | 80.00 | 87.00 | 73.00 | 70.00 | 65.00 | 72.00 | 58.00 | 32.00 | 21.00 | 14.00 | 14.00 | 40.00 | 30.00 |
Current Liabilities | 12.7% | 86.00 | 76.00 | 66.00 | 58.00 | 48.00 | 56.00 | 42.00 | 41.00 | 36.00 | 43.00 | 30.00 | 32.00 | 21.00 | 14.00 | 14.00 | 11.00 | 9.00 |
Shareholder's Equity | -3.8% | 447 | 465 | 452 | 436 | 427 | 417 | 415 | 414 | 419 | 239 | 234 | 222 | 214 | 200 | 191 | 184 | - |
Retained Earnings | -49.9% | -72.69 | -48.49 | -43.82 | -46.98 | -49.07 | -46.85 | -41.05 | -30.90 | -20.71 | -17.58 | -18.69 | -15.89 | -19.95 | -27.42 | -34.41 | -40.90 | -41.21 |
Additional Paid-In Capital | 2.8% | 518 | 504 | 497 | 484 | 476 | 463 | 457 | 446 | 440 | 257 | 253 | 238 | 234 | 228 | 226 | 225 | 2.00 |
Shares Outstanding | 0.4% | 58.00 | 58.00 | 58.00 | 57.00 | 55.00 | 54.00 | 53.00 | 53.00 | 51.00 | 50.00 | 50.00 | 50.00 | - | - | - | - | - |
Float | - | - | - | - | 2,830 | - | - | - | 3,280 | - | - | - | 3,950 | - | - | - | 954 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2018Q4 |
Cashflow From Operations | -200.4% | -12,288 | 12,241 | 15,939 | 9,760 | -2,013 | 11,255 | -13,066 | -3,061 | -9,100 | 15,007 | -5,589 | 7,302 | 8,766 | -1,624 | 5,341 | -1,126 | -679 | -826 | -335 | - | - |
Share Based Compensation | 31.3% | 12,870 | 9,801 | 9,844 | 10,353 | 10,339 | 7,596 | 7,356 | 7,164 | 6,555 | 4,509 | 12,499 | 4,604 | 3,836 | 1,565 | 959 | 506 | 494 | 176 | 139 | - | - |
Cashflow From Investing | 165.6% | 39,162 | -59,716 | 11,821 | -6,080 | -4,043 | -33,247 | 13,402 | -101,860 | -73,511 | -2,657 | -7,428 | -18,426 | -22,511 | -52,361 | -1,658 | -809 | -609 | -1,082 | -1,163 | - | - |
Cashflow From Financing | 142.1% | 1,015 | -2,410 | 3,467 | -2,352 | 2,466 | -1,689 | 3,880 | -1,595 | 176,542 | -620 | 2,993 | -514 | 2,214 | 226 | -30,531 | 164,398 | 10,022 | 10,025 | 178 | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 143,194,000 | $ 116,167,000 |
Cost of goods sold | 18,893,000 | 13,741,000 |
Gross profit | 124,301,000 | 102,426,000 |
Operating expenses | ||
Research and development | 26,880,000 | 22,064,000 |
Selling, general and administrative | 103,055,000 | 85,700,000 |
Change in fair value of contingent consideration | 6,303,000 | 0 |
Amortization of intangible asset | 2,461,000 | 0 |
Acquisition-related expenses | 2,779,000 | 0 |
Total operating expenses | 141,478,000 | 107,764,000 |
Loss from operations | (17,177,000) | (5,338,000) |
Other income (expense) | ||
Interest income | 1,191,000 | 4,145,000 |
Interest expense | (78,000) | (40,000) |
Other (expense) income | (23,000) | 39,000 |
Total other income | 1,090,000 | 4,144,000 |
Loss before income taxes | (16,087,000) | (1,194,000) |
Provision for income taxes | 8,115,000 | 1,024,000 |
Net loss | (24,202,000) | (2,218,000) |
Other comprehensive income (loss) | ||
Foreign currency translation adjustments | (7,359,000) | 9,000 |
Unrealized loss on available-for-sale debt securities | (4,000) | (865,000) |
Total other comprehensive loss | (7,363,000) | (856,000) |
Comprehensive loss | $ (31,565,000) | $ (3,074,000) |
Net loss per share | ||
Basic (in dollars per share) | $ (0.42) | $ (0.04) |
Diluted (in dollars per share) | $ (0.42) | $ (0.04) |
Weighted average common shares used to compute net loss per share | ||
Basic (in shares) | 57,938,115 | 54,756,024 |
Diluted (in shares) | 57,938,115 | 54,756,024 |
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 66,707,000 | $ 38,597,000 |
Restricted cash | 500,000 | 611,000 |
Short-term investments in debt securities | 34,595,000 | 76,855,000 |
Accounts receivable, net | 78,621,000 | 70,119,000 |
Inventories, net | 44,650,000 | 42,900,000 |
Prepaid expenses and other current assets | 8,240,000 | 6,481,000 |
Total current assets | 233,313,000 | 235,563,000 |
Property and equipment, net | 20,761,000 | 20,929,000 |
Operating lease right-of-use assets | 47,610,000 | 48,407,000 |
Goodwill | 209,642,000 | 214,335,000 |
Intangible assets | 145,774,000 | 150,884,000 |
Deposits and other assets | 4,676,000 | 4,117,000 |
Total assets | 661,776,000 | 674,235,000 |
Current liabilities | ||
Accounts payable | 12,026,000 | 10,577,000 |
Payroll-related accruals | 38,748,000 | 48,706,000 |
Accrued expenses and other current liabilities | 33,544,000 | 15,364,000 |
Operating lease liabilities, current portion | 1,719,000 | 1,692,000 |
Total current liabilities | 86,037,000 | 76,339,000 |
Operating lease liabilities, noncurrent portion | 29,773,000 | 30,355,000 |
Deferred tax liability | 35,395,000 | 36,231,000 |
Other long-term liability | 63,341,000 | 66,400,000 |
Total liabilities | 214,546,000 | 209,325,000 |
Commitments and contingencies (Note 9) | ||
Stockholders' equity | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $0.001 par value, 300,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 58,001,145 and 57,762,414 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 58,000 | 58,000 |
Additional paid in capital | 518,338,000 | 504,453,000 |
Accumulated other comprehensive income | 1,522,000 | 8,885,000 |
Accumulated deficit | (72,688,000) | (48,486,000) |
Total stockholders' equity | 447,230,000 | 464,910,000 |
Total liabilities and stockholders' equity | $ 661,776,000 | $ 674,235,000 |